JPMORGAN CHASE & CO

Position in XLO — Xilio Therapeutics, Inc.

CIK 19617 NEW YORK, NY

Position in XLO

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$2,018

+$1,974 QoQ

Shares Held

240

+287.1% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2021

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

JPMORGAN CHASE & CO holds $16,579,063,537 across 407 Biotechnology names. XLO ranks #319 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	24,150,499	$3,949,089,591
2	REGN	Regeneron Pharmaceuticals, Inc.	4,311,806	$3,331,473,778
3	VRTX	Vertex Pharmaceuticals Inc / Ma	7,033,156	$3,140,585,469
4	ALNY	Alnylam Pharmaceuticals, Inc.	6,323,752	$2,092,339,815
5	NUVL	Nuvalent, Inc.	3,088,349	$316,401,351
6	JAZZ	Jazz Pharmaceuticals plc	1,204,353	$227,682,931
7	IONS	Ionis Pharmaceuticals Inc	2,363,567	$177,480,242
8	TERN	Terns Pharmaceuticals, Inc.	2,869,728	$151,292,056

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,018	240	+287.1%	Shares	Defined	2026-05-13
2025-03-31	$44	62	-6.1%	Shares	Defined	2025-05-12
2024-12-31	$63	66	-12.0%	Shares	Defined	2025-02-12
2024-09-30	$59	75	+27.1%	Shares	Defined	2024-12-26
2024-06-30	$55	59	-97.8%	Shares	Defined	2024-12-26
2024-03-31	$2,963	2,744	-4.0%	Shares	Defined	2024-12-26
2023-12-31	$1,571	2,857	+5.0%	Shares	Defined	2024-12-26
2023-09-30	$5,743	2,722	+0.8%	Shares	Defined	2023-11-14
2023-06-30	$7,076	2,701	0.0%	Shares	Defined	2023-08-11
2023-03-31	$8,562	2,701	0.0%	Shares	Defined	2023-05-18
2022-12-31	$7,265	2,701	-0.1%	Shares	Defined	2023-02-13
2022-09-30	$7,868	2,704	-1.1%	Shares	Defined	2022-11-14
2022-06-30	$7,986	2,735	-43.5%	Shares	Defined	2022-08-11
2022-03-31	$34,246	4,844	-58.5%	Shares	Defined	2022-05-11
2021-12-31	$186,974	11,686	—	Shares	Defined	2022-02-11
No filing history on record for this holder in this stock.